1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Clonal Hematopoiesis of Indeterminate Potential: new trials by email Literature Review of Clonal Hematopoiesis of Indeterminate Potential trials Research Report on Clonal Hematopoiesis of Indeterminate Potential
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis Colchicine 0.5 mg orally once daily for 12 months., SoC therapy - Colchicine, Coronary Atherosclerosis Management | Phase 4 | Recruiting | Shenyang Northern Hospital | 120 | 2026-06-08 | 2026-10-01 |
Colchicine (1)
Shenyang Northern Hospital (1)
China (1)